 |
|
|
|
|
|
|
|
Right result…Right now.
Utilizing the most accurate and precise method available today, Primus provides a range of glycohemoglobin platforms to serve every need from the physician’s office to the largest reference laboratory. Boronate affinity technology provides a precise, accurate, rapid and interference-free method for reporting HbA1c. Affinity testing is the method of choice in the healthcare industry due to the inability of other methodologies to accurately quantitate GHb/A1c when interferences are present.
All Primus systems are certified by the National Glycohemoglobin Standardization Program (NGSP). Our A1c results are traceable to NGSP and IFCC. Primus Diagnostics is also a leader in the field of hemoglobinopathies, offering superior separations and fully automated hardware.
Primus enjoys a heritage of excellence…you can count on unequaled quality and dependability.
PDQ™ A1c Analyzer
The PDQ, our lightweight, compact HPLC system designed for minimal maintenance, incorporates the best features of Primus diagnostics to provide all the advantages of a large analyzer in a small footprint unit. It is available in two models—a single on-demand direct injection PDQ StandAlone or the automated PDQ Plus. Both units provide automatic sample dilution without operator intervention. Positive patient ID is achieved through the bar-code reading feature. The PDQ provides interference-free GHb/A1c results in 2 minutes with CV’s of <2%. Designed for use in the clinic and small to medium size laboratories.
This platform offers all of the advantages of the PDQ in a fully automated analyzer that provides sample processing of up to 28 patients per sample run. These instruments are precise, fast, versatile and easy to operate.
 |
|
|
|
 |
|
||
 |
 |
 |
|
 |
|
||
 |
|
||
 |
|
||
 |
|
||
 |
 |
||
 |
|
||
 |
|
||
 |
|
||